Genovis AB hires CFO

Genovis has hired Johny Humaloja to serve as CFO. Humaloja will assume the position in August and will be responsible for financial management and ongoing financial reporting at Genovis. 

Johny Humaloja, has extensive experience of financial control and management, primarily in biotechnology. He has previously worked as chief financial officer at international pharmaceutical companies such as Biogen and Boston Scientific. At Biogen’s North Carolina manufacturing plant in the US, which manufactures biological drugs, Johny mainly worked as Plant Controller. 

For more information, please contact: Fredrik Olsson, CEO, Genovis AB Tel: 0046 (0)46 -101233 fredrik.olsson@genovis.com

ABOUT GENOVIS

Genovis’ business concept is to apply its knowledge and imagination to design and provide innovative tools for the development of the drugs of the future. Today Genovis sells several enzyme products known as SmartEnzymes all over the world in innovative product formats that facilitate development and quality control of biological drugs.

The Group consists of Genovis AB and the wholly owned subsidiary Genovis Inc. (USA). Genovis shares are listed on Nasdaq First North Stockholm and Erik Penser Bank is the Company’s Certified Adviser, certifiedadviser@penser.se, T: +46 (0)8-463 83 00.